The drug's approval was based on two clinical trials of more than 1,800 patients who took either Xofluza, a placebo or another antiviral flu treatment within 48 hours of experiencing flu symptoms.
from WebMD Health https://ift.tt/2PndPu4
The drug's approval was based on two clinical trials of more than 1,800 patients who took either Xofluza, a placebo or another antiviral flu treatment within 48 hours of experiencing flu symptoms.
In a new study, scientists reported an increase in heart attacks in low temperature, strong wind, fewer hours of sunshine and low atmospheric pressure.
A seventh child has died after infection with an adenovirus at a health care facility in New Jersey, officials confirmed Wednesday. Eleven other children from the same facility are infected.
After adjusting for age, race, smoking and other factors, researchers have found a 19 percent higher risk of treatment-resistant blood pressure for every 15-microgram per gram increase in lead levels in the shin bone.